MiNK Therapeutics INKT Cash Flow Statement (2020-2026)

NASDAQ INKT
$10.06 -0.56 (-5.27%)
At close: Oct 22, 2026 · 4:00 PM EDT
Reported Financials

MiNK Therapeutics Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

MiNK Therapeutics reported cash from operations of -$2.08M and free cash flow of -$2.08M for the quarter ended Jun 2026, down 32.7% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-14.27M-5.76M-7.78M-6.11M-6.33M-7.77M-5.69M-6.20M-5.12M-5.46M-3.81M-2.70M-1.81M-2.46M-2.77M-4.24M-2.89M-2.60M-2.74M-3.13M
Depreciation and DepletionDep. & Depletion
0.02M0.02M0.03M0.03M0.03M0.04M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.04M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.02M0.03M0.03M0.03M0.04M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.04M
Share-based CompensationStock Comp.
0.39M0.67M0.04M0.00M0.77M0.67M0.03M0.03M0.94M1.10M0.03M0.03M0.88M0.39M0.01M0.90M0.62M0.57M0.63M0.42M
Gains from Sales and DivestituresGains Divest
0.00M-509.00
Other non-cash itemsOther Non-Cash
-0.36M
Change in Working Capital
Change in Account PayablesChange Payables
-0.61M1.35M0.64M0.97M0.48M0.57M0.15M-1.12M-0.58M-0.37M-0.42M-0.28M-0.85M0.37M-0.07M0.65M0.38M-0.27M-0.03M0.53M
Change in Accured ExpensesChange Accured Exp.
0.64M-1.30M1.19M0.37M0.00M1.86M-0.55M1.70M-0.39M1.26M0.32M-0.28M0.35M-0.78M0.10M-0.02M0.05M0.58M0.21M-0.25M
Change in Other Operating AssetsOther Assets Change
-0.16M-0.01M0.18M-0.08M0.16M0.04M0.01M-0.04M-0.22M0.01M0.01M0.04M0.14M0.01M-0.01M0.04M-0.02M0.02M-0.01M0.01M
Other Working Capital ChangesOther WC Changes
0.43M3.26M1.12M2.03M-0.41M0.24M0.76M0.74M0.66M0.39M0.73M0.52M0.58M0.40M0.55M0.58M0.61M0.18M0.16M0.32M
Cash from OperationsCash from Ops.
-3.50M-1.70M-4.20M-4.63M-5.61M-4.43M-4.37M-4.15M-4.21M-3.04M-2.54M-2.29M-2.99M-1.73M-1.34M-1.57M-0.94M-2.07M-1.73M-2.08M
Investing Activities
Capital ExpendituresCapex
0.11M-277.000.06M0.13M0.01M0.04M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.11M277.00-0.06M-0.13M-0.01M-0.04M-0.02M
Cash from Investing ActivitiesCash from Investing
-0.11M277.00-0.06M-0.13M-0.01M-0.04M-0.02M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
5.00M
Long-Term Debt RepaymentsLT Debt Repayment
5.00M
Non-Current Debt
5.00M-5.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
5.00M-5.00M
Change in Capital Stock
Common Stock IssuedStock Issued
39.80M689.00301.00494.00111.000.05M0.02M0.00M0.01M5.81M0.01M-3.00576.00540.0013.55M1.35M3.15M1.37M
Net Shares Issued and RepurchasedNet Shares Issued
39.80M689.00301.00494.00111.000.05M0.02M0.00M0.01M5.81M0.01M-3.00576.00540.0013.55M1.35M3.15M1.37M
Net Equity Issued and RepurchasedNet Equity Issued
39.80M689.00301.00494.00111.000.05M0.02M0.00M0.01M5.81M0.01M-3.00576.00540.0013.55M1.35M3.15M1.37M
Other financing activitiesOther financing
-0.38M-0.10M2.00-2.00-0.25M
Cash from Financing ActivitiesCash from Financing
2.78M39.80M689.00-0.16M494.00111.00-0.33M-0.08M0.00M-2.005.01M5.81M0.01M-3.00576.00540.0013.55M1.18M-2.10M1.37M
Additional items
Exchange Rate EffectFX Effect
-0.01M-0.03M0.00M0.00M-0.01M0.04M-0.03M-0.01M0.01M0.00M-0.01M-0.02M0.00M-0.02M0.00M0.02M-0.01M-0.02M0.00M0.00M
Change in Cash
-0.84M38.07M-4.20M-4.84M-5.69M-4.52M-4.74M-4.27M-4.22M-3.03M2.45M3.50M-2.99M-1.75M-1.34M-1.55M12.60M-0.92M-3.83M-0.72M
Ending Cash Balance
0.82M38.89M34.69M29.85M24.16M19.64M14.89M10.62M6.40M3.37M5.82M9.31M6.33M4.58M3.23M1.68M14.28M13.36M9.53M8.81M
Free Cash FlowFCF
-3.61M-1.70M-4.20M-4.63M-5.67M-4.56M-4.38M-4.19M-4.23M-3.04M-2.54M-2.29M-2.99M-1.73M-1.34M-1.57M-0.94M-2.07M-1.73M-2.08M
Net Cash FlowNCF
-0.82M38.10M-4.20M-4.78M-5.67M-4.56M-4.71M-4.26M-4.23M-3.04M2.46M3.52M-2.99M-1.73M-1.34M-1.57M12.60M-0.90M-3.83M-0.72M
Interest Paid
0.00M996.000.01M0.01M0.01M0.00M0.01M0.01M0.00M0.00M0.00M0.00M0.00M468.000.00M0.00M0.00M

MiNK Therapeutics Cash Flow Statement API

Pull MiNK Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INKT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY